首页> 外文期刊>Open Journal of Obstetrics and Gynecology >Role of Ovarian Fertility Sparing Surgery (FSS) in Cases of Early Stage 1 Ovarian Cancer in Patients in Reproductive Age Group
【24h】

Role of Ovarian Fertility Sparing Surgery (FSS) in Cases of Early Stage 1 Ovarian Cancer in Patients in Reproductive Age Group

机译:卵巢生育滥本手术(FSS)在生殖年龄组患者早期1阶段卵巢癌病例中的作用

获取原文
           

摘要

Objective : To assess the role of FSS in women with early stage 1 ovarian cancer. Methods : This was a retrospective analytic study of the results of treatment of 24 patients all under 40 years of age who underwent a full conservative staging laparotomy procedure in oncology center of El Shatby Maternity hospital, Alexandria University in the period of one year from October 2019 to September 2020. All patients were followed up for a six month period following surgery by the pre-operatively elevated tumor marker and by a CT abdomen and pelvis to detect any tumor recurrence . Results: The mean age at diagnosis was 24.29 Years. 6/24 (25%) of surface epithelial tumor were G1, 8/24 (33.3%) were G2, 4/24 (16.7%) were G3. 20/24 (83.3%) of patients were stage FIGO 1a, 4/25 (16.7%) were stage 1b, and none of them was stage 1c. 20/24 (83.3%) of patients were stage FIGO 1a, 4/25 (16.7%) were stage 1b, and none of them was stage 1c. Recurrence was reported in 3/24 of cases (12.5%), such 3 cases underwent unilateral SO plus a FCSLP. No recurrence was reported in cases of bilateral tumors that underwent unilateral SO and a contralateral cystectomy. 100% of recurrence was in epithelial tumors. 1/24 (4.1%) was clear cell, 1/24 (4.1%) was serous and 1/24 (4.1%) was mucinous. None of the endometroid tumors did recur. Also none of the non-epithelial tumors showed any recurrence. Tumors of G1 showed no recurrence, G2 tumors showed 33.3% recurrence and G3 tumors showed the highest recurrence rate (66.6%). Conclusion: ovarian FSS is a safe surgical option for nearly all OC patients with low risk of recurrence, with apparently early stage OC, after being confirmed by a FCSLP to exclude any occult metastasis (occult advanced stage OC), including those cases of early epithelial OC, germ cell and gonadal stromal tumors and it should be considered for patients who have a strong desire to keep their fertility.
机译:目标:评估FSS在早期1阶段卵巢癌妇女中的作用。 方法:这是一项回顾性的分析研究,治疗40岁以下患者的治疗结果,在此期间在El Shatby妇产医院肿瘤学中心进行了全保守的分期剖腹剖宫制程序从2019年10月到2020年10月的一年。所有患者随访六个月后,肿瘤标志物和CT腹部和骨盆和骨盆通过CT腹部和骨盆检测患者。 结果:诊断的平均年龄为24.29年。 6/24(25%)表面上皮肿瘤为G1,8 / 24(33.3%)为G2,4/24(16.7%)为G3。 20/24(83.3%)患者是阶段Figo 1a,4/25(16.7%)是第1B阶段,它们都不是第1℃。 20/24(83.3%)患者是阶段Figo 1a,4/25(16.7%)是第1B阶段,它们都不是第1℃。在3/24案(12.5%)中报告了复发,此类3例未完成单方面加上FCSLP。在双侧肿瘤的情况下报告了不接受单侧的双侧肿瘤和对侧膀胱切除术的情况下没有复发。 100%的再次发生是上皮肿瘤。 1/24(4.1%)是澄清的细胞,1/24(4.1%)浆液,1/24(4.1%)是粘液。没有一个内胞肿瘤肿瘤造成的。没有任何非上皮肿瘤表现出任何复发。 G1的肿瘤显示没有复发,G2肿瘤显示出33.3%的复发,G3肿瘤显示出最高的复发率(66.6%)。 结论:卵巢FSS是一种安全的手术选择,即几乎所有患者患有低患者的患者,明显早期OC,由FCSLP确认以排除任何潜水转移(隐匿性高级阶段OC),包括这些病例早期上皮OC,生殖细胞和性腺基质肿瘤,应考虑有强烈愿望生育的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号